At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
CM-1600device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Evaluation of the Zynex Monitoring System, Model CM-1600
In Brief
A clinical study evaluating CM-1600 for Fluid Loss. Completed, enrolled 20 participants across 1 site.
Detailed Summary
This is a prospective, single-arm, non-randomized, non-controlled single-center study for the evaluation of the Zynex CM-1600 in 20 healthy adults undergoing a manual blood loss of up to 500mL followed by an infusion of 1 liter of normal saline.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFluid Loss
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202420252026
Enrollment StartFeb 2023
Primary CompletionFeb 2023
First PostedFeb 2023
TodayJul 2026
First PostedFeb 23, 2023
Enrollment StartFeb 13, 2023
Primary CompletionFeb 22, 2023
TodayJul 2, 2026
Enrollment to primary: 9 daysPosted 3.4 years ago
Interventions
CM-1600device
Healthy subjects undergoing a manual blood loss of up to 500mL followed by an infusion of 1 liter of normal saline will be connected to the CM-1600 device.